S. Markovina

发表

Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation

J. Yodoi, D. Spitz, D. Gius, 2002, Oncogene.

Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase.

N. Horikoshi, D. Gius, C. M. Bradbury, 2001, Cancer research.

Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.

P. Parikh, D. Chang, S. Aggarwal, 2017, International journal of radiation oncology, biology, physics.

Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis

J. Michalski, H. Gay, S. Markovina, 2017, Advances in radiation oncology.

Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence.

P. Grigsby, B. Siegel, J. Moley, 2014, Thyroid : official journal of the American Thyroid Association.

Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with 18F-fluorodeoxyglucose–positron emission tomography in stage IB cervical cancer

Jason D. Wright, P. Grigsby, D. Mutch, 2019, International Journal of Gynecological Cancer.

Quality of Life Outcomes From a Phase 2 Trial of Short-Course Radiation Therapy Followed by FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer.

P. Parikh, J. Olsen, S. Hunt, 2016, International journal of radiation oncology, biology, physics.

Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side-Effect Profile.

P. Grigsby, A. Azab, C. Federico, 2020, International journal of radiation oncology, biology, physics.

A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer

P. Grigsby, J. Pfeifer, T. Baranski, 2018, Cancer medicine.

The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer

D. Mutch, P. Thaker, K. Fuh, 2020, Gynecologic oncology reports.

Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.

P. Grigsby, S. Mutic, D. Mutch, 2019, International journal of radiation oncology, biology, physics.

Low incidence of new biochemical hypogonadism after intensity modulated radiation therapy for prostate cancer.

J. Michalski, H. Gay, T. DeWees, 2014, Practical radiation oncology.

Three discipline collaborative radiation therapy (3DCRT) special debate: Equipment development is stifling innovation in radiation oncology

L. Kim, J. Burmeister, M. Dominello, 2019, Journal of applied clinical medical physics.

Integrating imaging and RNA-seq improves outcome prediction in cervical cancer.

P. Grigsby, J. Schwarz, S. Markovina, 2021, The Journal of clinical investigation.

Evidence for a phosphorylation-independent role for Ser 32 and 36 in proteasome inhibitor-resistant (PIR) IκBα degradation in B cells

S. Miyamoto, S. Markovina, S. O’Connor, 2005 .

The squamous cell carcinoma antigen/SERPINB3 protects cervical cancer cells from chemoradiation by preventing lysoptosis

P. Grigsby, G. Silverman, J. Schwarz, 2021 .

Radiologic Assessment of Groin Lymph Nodes in Pelvic Malignancies

P. Grigsby, D. Mutch, B. Siegel, 2020, International Journal of Gynecological Cancer.

Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation.

J. Yodoi, K. Hirota, D. Spitz, 2000, Cancer research.

Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

J. Shah, A. Iagaru, S. Mandel, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.

P. Grigsby, D. Mutch, J. Schwarz, 2019, Gynecologic oncology.

Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.

P. Grigsby, D. Mutch, Y. Rao, 2017, Gynecologic oncology.

Rebuttal to Drs. Hussein and Cooperberg.

J. Michalski, S. Markovina, 2015, Brachytherapy.

Point/Counterpoint Rebuttal to Drs. Hussein and Cooperberg

J. Michalski, S. Markovina, 2015 .

Common variable immunodeficiency with regulatory T-cell deficiency treated with rapamycin.

W. Grossman, M. Lokuta, A. Huttenlocher, 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Improving cervical cancer survival–A multifaceted strategy to sustain progress for this global problem

J. Schwarz, S. Grover, S. Markovina, 2022, Cancer.

Short-Term Endpoints for Neoadjuvant Rectal Cancer Therapy: Pathologic Complete Response or Neoadjuvant Rectal Cancer Score?

P. Parikh, J. Olsen, T. DeWees, 2016 .

FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival.

P. Grigsby, D. Mutch, B. Siegel, 2020, Gynecologic oncology.

Phase II Trial of Bevacizumab Combined with Low Dose Dexamethasone and Lenalidomide (BEV/REV/DEX) for Relapsed or Refractory Myeloma (MM).

N. Callander, S. Miyamoto, S. Markovina, 2007 .

Overall survival in patients with FIGO stage IVA cervical cancer.

P. Grigsby, P. Thaker, J. Schwarz, 2022, Gynecologic oncology.

Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.

P. Grigsby, D. Mutch, B. Siegel, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

Brachytherapy and survival in small cell cancer of the cervix and uterus.

P. Grigsby, J. Schwarz, S. Markovina, 2019, Brachytherapy.

Expression of Potential Biomarker Targets by Immunohistochemistry in Cervical Carcinomas

P. Grigsby, J. Pfeifer, I. Hagemann, 2022, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Detection of distant metastatic disease by positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma

P. Grigsby, B. Siegel, F. Dehdashti, 2019, International Journal of Gynecological Cancer.

DNMT1 as a Molecular Target in a Multimodality-Resistant Phenotype in Tumor Cells

P. Nguyen, R. Awwad, D. Gius, 2008, Molecular Cancer Research.

Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins

J. Fitzpatrick, G. Silverman, C. Luke, 2022, Communications Biology.

Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma Cells

KyungMann Kim, N. Callander, S. Miyamoto, 2008, Molecular Cancer Research.

Counterpoint: Unfair comparisons lead to unwarranted conclusions-Can treatment modalities for localized prostate cancer truly be compared without bias?

J. Michalski, S. Markovina, 2015, Brachytherapy.

Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities.

S. Markovina, Z. Morris, R. Sriramaneni, 2018, Brachytherapy.

HPV transcript expression affects cervical cancer response to chemoradiation

Christopher A. Miller, P. Grigsby, M. McLellan, 2021, JCI insight.

Neutrophils promote tumor resistance to radiation therapy

Cierra S. Hong, D. Kirsch, Yarui Diao, 2019, Proceedings of the National Academy of Sciences.

SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation

P. Grigsby, G. Silverman, J. Schwarz, 2022, Communications Biology.

Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities.

S. Markovina, Z. Morris, R. Sriramaneni, 2019, Brachytherapy.

Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma

N. Callander, L. Rui, M. Huynh, 2017, The Journal of Biological Chemistry.

Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas

P. Grigsby, H. Tiwari, C. Pedamallu, 2021, Cancers.

Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.

James B. Mitchell, M. Brechbiel, L. Neckers, 2003, Cancer research.

Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma

K. Young, S. Miyamoto, S. Markovina, 2008, Molecular Cancer.

Early posttherapy clearance of human papillomavirus and treatment response in cervical carcinoma.

P. Grigsby, J. Schwarz, A. Srivastava, 2020, Cancer.

Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235.

J. Bradley, B. Siegel, F. Duan, 2015, International journal of radiation oncology, biology, physics.

Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells

KyungMann Kim, N. Callander, S. Miyamoto, 2010, Molecular Cancer.

SCCA1/SERPINB3 promotes suppressive immune environment via STAT-dependent chemokine production, blunting the therapy-induced T cell responses

P. Grigsby, J. Schwarz, P. Cosper, 2023, bioRxiv.

Radiation therapy dose escalation for glioblastoma multiforme in the era of temozolomide.

E. Leuthardt, G. Linette, D. Tran, 2014, International journal of radiation oncology, biology, physics.

Decreased local immune response and retained HPV gene expression during chemoradiotherapy are associated with treatment resistance and death from cervical cancer

P. Grigsby, Xiaowei Wang, K. Knudsen, 2019, International journal of cancer.

The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignancies.

P. Grigsby, J. Schwarz, M. Powell, 2022, Gynecologic oncology.

Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.

P. Grigsby, J. Williamson, J. Schwarz, 2019, Brachytherapy.

Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus

P. Parikh, J. Olsen, T. Mazur, 2017, Advances in radiation oncology.

Residual Post-Treatment FDG Avidity in Regional Lymph Nodes Impacts Local-Regional Control in Patients Receiving Definitive Chemoradiation for Non-small Cell Lung Cancer: A Secondary Analysis of ACRIN 6668/RTOG 0235

J. Bradley, B. Siegel, F. Duan, 2014 .

Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer

P. Grigsby, D. Mutch, P. Thaker, 2020, International Journal of Gynecological Cancer.

Mono- and diunsaturated fatty acids sensitize cervical cancer to radiation therapy.

Kevin Cho, G. Patti, J. Schwarz, 2022, Cancer research.

Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer

P. Grigsby, Xiaowei Wang, D. Mutch, 2017, British Journal of Cancer.

The role of thioredoxin in the regulation of AP-1 DNA-binding and cytotoxicity in response to ionizing radiation ASTRO research fellowship

D. Gius, C. M. Bradbury, I. Zoberi, 2000 .

Phase I Trial of Stereotactic MRI-guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer.

P. Grigsby, P. Thaker, K. Fuh, 2021, International journal of radiation oncology, biology, physics.

Standardized Uptake Value for 18F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer

P. Grigsby, B. Siegel, F. Dehdashti, 2021, Clinical Cancer Research.

SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production

P. Grigsby, Subhajit Ghosh, J. Schwarz, 2023, The Journal of clinical investigation.

Acetyl-l-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network

N. Callander, J. Eickhoff, S. Miyamoto, 2014, Cancer Chemotherapy and Pharmacology.

Evidence for a phosphorylation-independent role for Ser 32 and 36 in proteasome inhibitor-resistant (PIR) IkappaBalpha degradation in B cells.

S. Miyamoto, S. Markovina, Shelby L. O’Connor, 2005, Experimental cell research.

Pre-Treatment [F-18]FDG-PET SUVmax as a Prognostic and Radiogenomic Marker in Cervical Cancer

P. Grigsby, J. Schwarz, T. DeWees, 2018, International Journal of Radiation Oncology, Biology, Physics.

Sustained Response with Dose-reduced Selpercatinib in a Pediatric Patient with Metastatic NCOA4-RET Fusion Papillary Thyroid Carcinoma.

P. Grigsby, S. Markovina, Amy E Armstrong, 2023, Journal of pediatric hematology/oncology.

Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer

Christopher A. Miller, R. Fulton, P. Grigsby, 2017, Oncotarget.

Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.

P. Grigsby, S. Mutic, D. Mutch, 2019, International journal of radiation oncology, biology, physics.